On May 30, 2023 Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, reported that the Company will present at the following upcoming investor conferences during the month of June (Press release, Dynavax Technologies, MAY 30, 2023, View Source [SID1234632265]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6 at 9:20 a.m. CT
Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12 at 11:20 a.m. PT
The presentations will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company’s website at View Source